Evidence map›Paper›PMID 28706448›Full record

ArticleInfection and drug resistance2017

Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand.

Risara Jaksuwan, Prasit Tharavichikul, Jayanton Patumanond, Charoen Chuchottaworn, Sakarin Chanwong, Saijai Smithtikarn, Jongkolnee Settakorn

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Epidemiology of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Pooled it
  2. Article
  3. Article
  4. Prevalence ofJournal of clinical tuberculosis and other mycobacterial diseases · 2023
    Article
  5. Article
  6. Article
  7. Use of Whole-Genome Sequencing to PredictMicrobiology spectrum · 2022
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Risara JaksuwanClinical Epidemiology Unit.
Prasit TharavichikulDepartment of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai.
Jayanton PatumanondDivision of Clinical Epidemiology, Faculty of Medicine, Thammasat University, Pathum Thani.
Charoen ChuchottawornDivision of Respiratory Medicine, Chest Disease Institute, Nonthaburi.
Sakarin ChanwongOffice of Disease Prevention and Control Region 10, Chiang Mai.
Saijai SmithtikarnBureau of Tuberculosis, Department of Disease Control, Ministry of Public Health, Bangkok.
Jongkolnee SettakornDepartment of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Chiang Mai University · THCentral Chest Institute of Thailand · THMRC Epidemiology Unit · GBOffice of Disease Prevention · USThammasat University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMultidrug/extensively drug-resistant tuberculosis (M/XDR-TB) is a major public health problem, and early detection is important for preventing its spread. This study aimed to demonstrate the distribution of genetic site mutation associated with drug resistance in M/XDR-TB in the northern Thai population.

methodsThirty-four clinical MTB isolates from M/XDR-TB patients in the upper northern region of Thailand, who had been identified for drug susceptibility using the indirect agar proportion method from 2005 to 2012, were examined for genetic site mutations of

resultsAll 34 isolates resisted both INH and RIF. Thirty-two isolates (94.1%) showed a mutation of at least 1 codon for

conclusionThe genetic mutation sites for drug resistance in M/XDR-TB are quite variable. The distribution of these mutations in a certain population must be studied before developing the specific mutation test panels for each area. The results of this study can be applied for further molecular M/XDR-TB diagnosis in the upper northern region of Thailand.

Indexed as

drug resistancegenotypeMDR-TBmutationtuberculosisXDR-TB

Identifiers

PMID28706448
PMCPMC5495008
OpenAlexW2623236826

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.